NEW YORK (GenomeWeb News) – Response Genetics today said it has signed agreements with four payors to provide access to the molecular diagnostic firm's tests.
The deals are with America's Choice Provider Network, FedMed, Galaxy Health Network, and Prime Health Services, and increases the number of people in the US who now have access to Response's tests by 54 million, the company said. It added that in 2013, it has entered into a total of six PPO network contracts providing access to its tests to more than 135 million Americans.
Los Angeles-based Response offers genomic testing focused on lung, colon, and gastric cancer, as well as melanoma. The tests are used by physicians to help guide them in choosing therapeutic treatments for their patients.
Last week, the company reported that revenues in its third quarter decreased 24 percent year over year to $4.1 million.